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ABSTRACT 
 
 
 
 
A. Paniculata or also called bile of heart is herb always used in traditional 
Malaysian medicine for treatment of a wide range of diseases such as diabetes, diarrhea 
and snake bites. The main bioactive compound which is andrographolide act as an 
antioxidant, protecting the liver and digestive system, antimicrobial and others. This 
research is to study the efficiency of niosome in entrapment of bioactive compound 
(andrographolide).  The aerial part of plant were taken and extracted in the solvent. The 
solvent used are ethanol and distilled water. Six of niosomal formulation for the delivery 
of andrographolide will be developing to achieve effectiveness in entrapment of 
andropholide. The primary metabolites of A. Paniculata were found and the result shows 
the water extract have the higher total protein (901.875 mg/mL ± 0.0021) and ethanol 
extract have the higher glycosaponin in extract (40% ± 0.0021). Zeta potential were in the 
range of -30mV to -40mV while particle size in the range of 90nm to 200nm. Zeta 
potential and particle size of niosome indicated all the formulation were stable. Drug 
entrapment efficiency in the niosomes will be determined spectrophotometrically. 
Formulation with ethanol solvent extract and surfactant: cholesterol ratio in 0.50: 0.50; F5 
indicated the best formulation and give the optimum entrapment of A. Paniculata extract 
(7.431ppm of andrographolide). The result delivered that this niosomal formulation is 
determined greatly helpful to improve the encapsulation efficiency of drugs and reduce 
the release rate of the drug. This study provides a new insight into designing effective 
niosomal system.   
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ABSTRAK 
 
 
 
 
A. Paniculata atau juga dipanggil “Hempedu Bumi” adalah tumbuhan herba yang 
sering digunakan dalam pengubatan tradisional di Malaysia untuk merawat pelbagai 
penyakit seperti diabetes, cirit-birit dan gigitan ular. Komponen bioaktif yang utama di 
dalam tumbuhan A. Paniculata adalah andrographolide yang bertindak sebagai antioksida, 
menjaga hati dan sistem penghadaman, antimikrob dan sebagainya. Kajian yang 
dijalankan ini adalah untuk  mengenalpasti tahap kecekapan niosome dalam memerangkap 
komponen bioaktif (andrographolide). Seluruh bahagian tumbuhan dikeringkan dan 
diekstrak di dalam larutan ethanol dan air suling. Sebanyak enam formulasi niosome 
dikenalpasti untuk mengangkut andrographolide dan mendapatkan keberkesanan dan 
kecekapan niosome dalam memerangkap andrographolide. Metabolit pertama bagi A. 
Paniculata telah dikenalpasti dan hasil dari kajian menunjukkan bahawa ekstrak air 
mempunyai jumlah protein yang tinggi (901.875 mg/mL ± 0.0021) dan ekstrak etanol pula 
mempunyai glycosaponin yang paling tinggi (40% ± 0.0021). Zeta potential menunjukkan 
keputusan di antara skala -30mV hingga -40mV manakala saiz zarah niosome di antara 
90nm hingga 200nm. Zeta potential dan saiz zarah niosome menunjukkan bahawa semua 
formula adalah stabil. Kadar kecekapan pemerangkapan niosome akan dikenalpasti secara 
spektrofotometrik. Formulasi dengan menggunakan ekstrak etanol dan nisbah surfakten: 
kolesterol, 0.50: 0.50; F5 menunjukkan formulasi yang terbaik dan ianya memberikan 
pemerangkap ekstrak A. Paniculata yang optimum (7.431ppm andrographolide). Dapatan 
dari keputusan bahawa formulasi niosome ini dapat membantu dalam meningkatkan tahap 
kecekapan dalam memerangkap andrographolide dan mengurangkan kadar pelepasan 
bioaktif komponen tersebut. Kajian ini diharap dapat menyediakan idea baru dalam 
merekacipta tahap sistem kecekapan ini. 
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CHAPTER 1 
 
 
 
 
INTRODUCTION 
 
 
 
 
1.0 Background of the study  
 
 
In traditional drug delivery system such as oral ingestion or intravascular injection, 
the drug is distributed throughout the body through the blood circulation. For therapeutic 
agents, only a small portion of medication contact with the organs are affected. Targeted 
drug delivery seeks to concentrate the medication in the tissues of interest while reducing 
the relative concentration of the medication in the remaining tissues. 
 
 
The basic principle of drug delivery has been developed over previous decades. 
The aim of a targeted drug delivery system is to prolong, localize, target and have a 
protected drug interaction with the diseased tissue. Besides, drug delivery also provide 
many ways to increase absorption into the brain, lengthen a drug’s action, carry it to a 
targeted part of the body or get other desired effects. 
 
Drug delivery system has several types of drug carrier. Some of the most 
commonly used for drug carrier system such as liposomes, microsphere, soluble polymers, 
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conjugated proteins, niosomes and nanoparticles. Each drug carriers have different 
structure and specific uses. Moreover, the best drug carrier must biodegradable, non-toxic, 
non-immunogenic, biocompatible and avoid recognition by the host's defense 
mechanisms.  
 
 
 
 
1.1 Statement of the problem  
 
 
The drug carrier bioactive compounds such as liposome or niosome have distinct 
advantages over conventional dosage forms. These nano-carriers as drug delivery system 
have been utilized to direct drug at the target organ or tissue. Many bioactive compounds 
have limited aqueous solubility, so there is a great need for delivery systems suitable for 
both hydrophobic and hydrophilic drugs. Liposomes and niosomes can carry hydrophilic 
drugs and hydrophobic drugs. Liposomes have been used to reduce toxicity, increase drug 
stability, enhance therapeutic effects, prolong circulation time and promote uptake of the 
entrapped drugs into the target site. However, liposome has some disadvantages which are 
poor stability due to hydrolysis of phospholipid molecules and high manufacturing costs 
of phospholipids.  
 
 
Alternatively, non-ionic surfactant vesicles or niosome whose are similar to 
liposomes have been developed. This non-ionic surfactant do not produce ions in aqueous 
solution and exhibit a very low toxicity level. Technically, niosomes are promising drug 
carriers because they have greater stability and lower cost. Niosomes also have the 
advantages of simple method of production for the routine laboratory use and its 
biodegradable. (Shatalebi et. al. 2010).  
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For this reason, niosome is chosen in this present study focusing on efficiency in 
entrapment of A. paniculata extract as the nano-carrier to facilitate the active compound 
in delivery system. 
 
 
 
 
1.2 Objective of the study  
 
 
The objective from this research is to investigate the efficiency of niosome in 
entrapment of A. paniculata extract. 
 
 
 
 
1.3 Scope of the study 
 
 
The scopes from this research are: 
 
1. Determination of A. paniculata extract primary metabolites.  
 
2. Determination of particle size and stability of A. paniculata extract in niosome. 
 
3. Determination and characterization of niosome in entrapment efficiency of A. 
paniculata extract. 
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1.4 Significant of the study 
 
 
A. paniculata is widely used in traditional medicine among Asian community. This 
traditional herb medicine has been reported to have wound healing capacity because the 
main bioactive compound which is andrographolide is supposed to exhibit anti-
inflammatory effect. However, the application of topical delivery system contain in this 
plant material is yet has not been studied. The importance of this study is to overcome the 
limitation in topical application contained plant extract which mostly has the characteristic 
of hydrophobic compounds. Niosomes are non-ionic surfactant vesicles that have 
potential applications in the delivery of hydrophilic and hydrophobic drugs. Thus, by 
incorporating the A. paniculata extract into the niosome can overcome the limitation in 
topical wound healing product. 
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